|
Model Number B3300542 |
Device Problems
Break (1069); High impedance (1291)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/22/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that, during the patients stage two dbs procedure, an impedance test revealed elevated impedances on the right dbs lead construct, specifically impacting contact 10b. there were no noted/stated factors that may have contributed to the issue. the right side lead construct was disassembled, cleaned and reconnected.The impedance issue persisted.Using a lead test cable to cranial lead was tested individually and this showed identical results to those seen when testing the fully assembled dbs system.This lead the physician to determine that the right cranial lead was the cause of the impedance issue. following troubleshooting noted above, the physician elected to proceed with the procedure recognizing that the lead had sustained some damage which appears to involve contact 10b.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported the cause of the damage wasn¿t determined as visual inspection of the exposed length of the lead showed no evidence of damage or defect.To try and resolve the damage to contact 10b the connection of the lead/extension construct was cleaned and dried with sterile cotton gauze.The reported damage occurred during the stage two produce for this patient, with initial programming not yet occurring.
|
|
Search Alerts/Recalls
|
|
|